{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:24:15Z","timestamp":1774884255522,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japanese Society for the Promotion of Science","doi-asserted-by":"crossref","award":["23K16438"],"award-info":[{"award-number":["23K16438"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10147-025-02850-x","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T16:19:09Z","timestamp":1755101949000},"page":"1896-1905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Opioid switching to improve delirium symptoms in patients with cancer: a systematic review"],"prefix":"10.1007","volume":"30","author":[{"given":"Kousuke","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7894-4528","authenticated-orcid":false,"given":"Takaaki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-9377","authenticated-orcid":false,"given":"Yoshinobu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8375-4040","authenticated-orcid":false,"given":"Hitoshi","family":"Tanimukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-4339","authenticated-orcid":false,"given":"Saho","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6875-6275","authenticated-orcid":false,"given":"Jun","family":"Kako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Japan Psycho-Oncology Society\/the Japanese Association of Supportive Care in Cancer\u2019s Clinical Practice Guidelines for Delirium in Cancer Patients Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Tanimukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saho","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Inada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiharux","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuichi","family":"Kitaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Shinsato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Niki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntaro","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"2850_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1176\/appi.psy.43.3.183","volume":"43","author":"W Breitbart","year":"2002","unstructured":"Breitbart W, Gibson C, Tremblay A (2002) The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses\/caregivers, and their nurses. Psychosomatics 43:183\u2013194","journal-title":"Psychosomatics"},{"key":"2850_CR2","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1200\/JCO.2011.37.3795","volume":"30","author":"M Maltoni","year":"2012","unstructured":"Maltoni M, Scarpi E, Rosati M et al (2012) Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol 30:1378\u20131383","journal-title":"J Clin Oncol"},{"key":"2850_CR3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/0269216319854944","volume":"33","author":"CL Watt","year":"2019","unstructured":"Watt CL, Momoli F, Ansari MT et al (2019) The incidence and prevalence of delirium across palliative care settings: a systematic review. Palliat Med 33:865\u2013877","journal-title":"Palliat Med"},{"issue":"Supplement 4","key":"2850_CR4","doi-asserted-by":"publisher","first-page":"iv143","DOI":"10.1093\/annonc\/mdy147","volume":"29","author":"SH Bush","year":"2018","unstructured":"Bush SH, Lawlor PG, Ryan K et al (2018) Delirium in adult cancer patients: ESMO clinical practice guidelines. Ann Oncol 29(Supplement 4):iv143\u2013iv165","journal-title":"Ann Oncol"},{"key":"2850_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0885-3924(01)00360-8","volume":"22","author":"T Morita","year":"2001","unstructured":"Morita T, Tei Y, Tsunoda J et al (2001) Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 22:997\u20131006","journal-title":"J Pain Symptom Manage"},{"key":"2850_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(13)60688-1","volume":"383","author":"SK Inouye","year":"2014","unstructured":"Inouye SK, Westendorp RG, Saczynski JS (2014) Delirium in elderly people. Lancet 383:911\u2013922","journal-title":"Lancet"},{"key":"2850_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.genhosppsych.2020.09.001","volume":"67","author":"I Maeda","year":"2020","unstructured":"Maeda I, Ogawa A, Yoshiuchi K et al (2020) Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: a large-scale multicenter prospective observational study in real-world palliative care settings. Gen Hosp Psychiatry 67:35\u201341","journal-title":"Gen Hosp Psychiatry"},{"key":"2850_CR8","unstructured":"WHO guidelines approved by the guidelines review committee (2018) WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. World Health Organization, Geneva \u00a9 World Health Organization"},{"key":"2850_CR9","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/JCO.22.02198","volume":"41","author":"JA Paice","year":"2023","unstructured":"Paice JA, Bohlke K, Barton D et al (2023) Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline [ASCO guideline]. J Clin Oncol 41:914\u2013930","journal-title":"J Clin Oncol"},{"key":"2850_CR10","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/jpm.2021.0438","volume":"25","author":"H Mawatari","year":"2022","unstructured":"Mawatari H, Shinjo T, Morita T et al (2022) Revision of pharmacological treatment recommendations for cancer pain: clinical guidelines from the Japanese society of palliative medicine. J Palliat Med 25:1095\u20131114","journal-title":"J Palliat Med"},{"key":"2850_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s11864-023-01117-9","volume":"24","author":"S Mercadante","year":"2023","unstructured":"Mercadante S (2023) Opioid-induced neurotoxicity in patients with cancer pain. Curr Treat Options Oncol 24:1367\u20131377","journal-title":"Curr Treat Options Oncol"},{"key":"2850_CR12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/jjco\/hyad042","volume":"53","author":"Y Matsuda","year":"2023","unstructured":"Matsuda Y, Tanimukai H, Inoue S et al (2023) A revision of JPOS\/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol 53:808\u2013822","journal-title":"Jpn J Clin Oncol"},{"key":"2850_CR13","doi-asserted-by":"crossref","unstructured":"Quigley C (2004) Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 3:CD004847","DOI":"10.1002\/14651858.CD004847"},{"key":"2850_CR14","doi-asserted-by":"crossref","unstructured":"Dale O, Moksnes K, Kaasa S pain guidelines (2011) European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review. Palliat Med 25:494\u2013503","DOI":"10.1177\/0269216310384902"},{"key":"2850_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18:e1003583","journal-title":"PLoS Med"},{"key":"2850_CR16","unstructured":"Japan Council for Quality Health Care. The Minds Guideline Creation Manual. https:\/\/minds.jcqhc.or.jp\/. Accessed Oct 20, 2024"},{"key":"2850_CR17","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"2850_CR18","first-page":"153","volume":"16","author":"C Takigawa","year":"2009","unstructured":"Takigawa C, Ky UK, Morimoto Y (2009) Efficacy of partial opioid rotation of morphine to intravenous compound oxycodone for morphine-induced delirium in advanced cancer patients. J Jpn Soc Pain Clin 16:153\u2013157","journal-title":"J Jpn Soc Pain Clin"},{"key":"2850_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jpainsymman.2004.12.010","volume":"30","author":"T Morita","year":"2005","unstructured":"Morita T, Takigawa C, Onishi H et al (2005) Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial. J Pain Symptom Manage 30:96\u2013103","journal-title":"J Pain Symptom Manage"},{"key":"2850_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1017\/S1478951505050479","volume":"3","author":"N Moryl","year":"2005","unstructured":"Moryl N, Kogan M, Comfort C et al (2005) Methadone in the treatment of pain and terminal delirum in advanced cancer patients. Palliat Support Care 3:311\u2013317","journal-title":"Palliat Support Care"},{"key":"2850_CR21","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1002\/cncr.20712","volume":"101","author":"MA Ben\u00edtez-Rosario","year":"2004","unstructured":"Ben\u00edtez-Rosario MA, Feria M, Salinas-Mart\u00edn A et al (2004) Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 101:2866\u20132873","journal-title":"Cancer"},{"key":"2850_CR22","first-page":"265","volume":"7","author":"B Gagnon","year":"1999","unstructured":"Gagnon B, Bielech M, Watanabe S et al (1999) The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Support Care Cancer 7:265\u2013270","journal-title":"Support Care Cancer"},{"key":"2850_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0885-3924(96)00050-4","volume":"12","author":"I Maddocks","year":"1996","unstructured":"Maddocks I, Somogyi A, Abbott F et al (1996) Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage 12:182\u2013189","journal-title":"J Pain Symptom Manage"},{"key":"2850_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jpainsymman.2023.04.026","volume":"66","author":"S Mercadante","year":"2023","unstructured":"Mercadante S, Cascio AL, Casuccio A (2023) Switching to intravenous methadone in advanced cancer patients: a retrospective analysis. J Pain Symptom Manage 66:287\u2013292","journal-title":"J Pain Symptom Manage"},{"key":"2850_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamainternmed.2016.7491","volume":"177","author":"MR Agar","year":"2017","unstructured":"Agar MR, Lawlor PG, Quinn S et al (2017) Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med 177:34\u201342","journal-title":"JAMA Intern Med"},{"key":"2850_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S1470-2045(20)30307-7","volume":"21","author":"D Hui","year":"2020","unstructured":"Hui D, De La Rosa A, Wilson A et al (2020) Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. Lancet Oncol 21:989\u2013998","journal-title":"Lancet Oncol"},{"key":"2850_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0885-3924(01)00250-0","volume":"21","author":"S Mercadante","year":"2001","unstructured":"Mercadante S, Portenoy RK (2001) Opioid poorly responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage 21:338\u2013354","journal-title":"J Pain Symptom Manage"},{"key":"2850_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/archinte.160.6.786","volume":"160","author":"PG Lawlor","year":"2000","unstructured":"Lawlor PG, Gagnon B, Mancini IL et al (2000) Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 160:786\u2013794","journal-title":"Arch Intern Med"},{"key":"2850_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","volume":"57","author":"ML McPherson","year":"2019","unstructured":"McPherson ML, Walker KA, Davis MP et al (2019) Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manag 57:635-645.e4","journal-title":"J Pain Symptom Manag"},{"key":"2850_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1634\/theoncologist.2015-0503","volume":"21","author":"J Porta-Sales","year":"2016","unstructured":"Porta-Sales J, Garz\u00f3n-Rodr\u00edguez C, Villavicencio-Ch\u00e1vez C et al (2016) Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study. Oncologist 21:981\u2013987","journal-title":"Oncologist"},{"issue":"Supplement","key":"2850_CR31","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","volume":"18","author":"CE Inturrisi","year":"2002","unstructured":"Inturrisi CE (2002) Clinical pharmacology of opioids for pain. Clin J Pain 18(Supplement):S3\u2013S13","journal-title":"Clin J Pain"},{"key":"2850_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1526-4637.2008.00461.x","volume":"9","author":"DJ Weschules","year":"2008","unstructured":"Weschules DJ, Bain KT (2008) A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med 9:595\u2013612","journal-title":"Pain Med"},{"key":"2850_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1155\/2003\/236718","volume":"8","author":"B Gagnon","year":"2003","unstructured":"Gagnon B, Almahrezi A, Schreier G (2003) Methadone in the treatment of neuropathic pain. Pain Res Manag 8:149\u2013154","journal-title":"Pain Res Manag"},{"key":"2850_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpain.2014.01.494","volume":"15","author":"R Chou","year":"2014","unstructured":"Chou R, Cruciani RA, Fiellin DA et al (2014) Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain 15:321\u2013337","journal-title":"J Pain"},{"key":"2850_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","volume":"50","author":"A Ferrari","year":"2004","unstructured":"Ferrari A, Coccia CP, Bertolini A et al (2004) Methadone\u2014metabolism, pharmacokinetics and interactions. Pharmacol Res 50:551\u2013559","journal-title":"Pharmacol Res"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02850-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:38:22Z","timestamp":1758872302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02850-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2850"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02850-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Matsuda has received lecture fees from Hisamitsu Pharmaceutical Co., Inc., Fujimoto Pharmaceutical Corporation, Takeda Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Chugai Pharmaceutical Co., Ltd., AstraZeneca Co., Ltd., Daiichi Sankyo Co., Ltd., and Eisai Co., Ltd. The other authors indicated no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}